CDKN2B and colon adenocarcinoma: Our data also records the significant downregulation of lncRNA CDKN2B-AS1, which was also found to be aberrantly expressed and is suggested as an optimal diagnostic lncRNA biomarker for COAD by Huang et al.,47.